Your SlideShare is downloading. ×
0
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Other SEP Activities - 17th Texas HIV/STD Conference
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Other SEP Activities - 17th Texas HIV/STD Conference

349

Published on

Implications of Lifting the Federal Funding Ban on Syringe Exchange at Texas HIV/STD Conference. Powerpoint by Dan Bigg, Chicago Recovery Alliance. Please use with credit to Chicago Recovery …

Implications of Lifting the Federal Funding Ban on Syringe Exchange at Texas HIV/STD Conference. Powerpoint by Dan Bigg, Chicago Recovery Alliance. Please use with credit to Chicago Recovery Alliance. Dan @ cra@attglobal.net or anypositivechange.org

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
349
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Harm Reduction in Chicago The Power of Any Positive Change! Chicago Recovery Alliance
  • 2. Low Threshold Treatment Options - All are Welcome
  • 3.  
  • 4.  
  • 5.  
  • 6.  
  • 7.  
  • 8.  
  • 9. Harm Reduction --> Community Improvement
  • 10.  
  • 11.  
  • 12.  
  • 13. Making a Safer Shot Starting Point?
  • 14. More Accurate!
  • 15. <ul><li>Candidates for Hepatitis A Vaccination </li></ul><ul><li>High-risk populations </li></ul><ul><li> * Users of illegal drugs. </li></ul><ul><li>Candidates for Hepatitis B Vaccination </li></ul><ul><li>High-risk populations </li></ul><ul><li> * Injection drug users. </li></ul>
  • 16. <ul><li>Despite the long-standing existence of unambiguous recommendations for risk group vaccination , hepatitis B vaccination coverage remains low in most risk groups in most high-income countries. This low coverage may be attributed to a lack of perceived risk of hepatitis B and the absence of appropriate health care programmes targeting hepatitis B monitoring and vaccination for certain risk groups, particularly sex workers, injecting drug users, and prisoners… The VHPB also recognises that new strategies will have to be developed and implemented . </li></ul><ul><li>Hepatitis B vaccination: how to reach risk groups. Francois G, Hallauer J, Van Damme P. </li></ul><ul><li>Vaccine 2002 Nov 22;21(1-2):1-4 </li></ul>
  • 17. <ul><li>The Berkeley Free Clinic </li></ul><ul><li>Health Care for People Not Profit </li></ul>http://www.berkeleyfreeclinic.org Hepatitis Testing, Education and Vaccination (Hep-TEV) Service is open only to people at risk for hepatitis. Hep-TEV provides anonymous or confidential testing and counseling for hepatitis A, B and C. The hepatitis clinic is open Saturdays between 3 and 5. Those interested should call between 1 and 2:30pm on Saturday for a same-day appointment at (800) 6-CLINIC.
  • 18. Pneumococcal Seasonal Flu H1N1 Flu Hep A/B Combined Hep A and Hep B separately Tetanus
  • 19. Vaccination Experience to Date… 46,270 vaccinations completed over last decade (84% latest completion figures); Some staff take longer than others to get up to speed -- more hands on training and on-site support; Physician skilled in work with drug users critical to program success; Could not happen without CDPH vaccine!
  • 20. Enough Motivation to Address OD? Program
  • 21. Opiate Overdose Prevention and Intervention in Chicago Use of a proven antidote to save lives where they are being lost on the streets CRA’s OD work dedicated to John Szyler as Any Positive Change
  • 22.  
  • 23.  
  • 24. CRA’s Opiate Overdose Prevention/Intervention Work…
  • 25.  
  • 26.  
  • 27. All Testing Possible… Rapid HIV ab – oral or finger stick Syphilis + HCV ab ALL TESTING POSSIBLE… Chlamydia/Gonorrhea
  • 28. CRA Annual Report 2009 11,021 visits 6,341 unique participants 3.06 million syringes exchanged 30.8% female, 1% trans 55% W, 31% AA, 9% PR, 4% Mex 32% 20-24, 25% 30-44, 23% 44+, 12% 25-29, 7% 13-19
  • 29. Harm Reduction --> Community Improvement Bridge to Life Improvements - 300 new methadone treatment admissions in 40 days - Spring ‘00
  • 30.  
  • 31.  
  • 32.  
  • 33.  
  • 34. MOST <ul><li>Mobile Opiate Substitution Therapies </li></ul>
  • 35.  
  • 36.  
  • 37.  
  • 38.  
  • 39. <ul><li>MOST Twenty Month Trial Ended July 2007. Lessons: </li></ul><ul><li>Successful engagement tool through any positive change </li></ul><ul><li>All risk reduction tools INCREASED engagement and did not prevent or reduce relationships!! </li></ul><ul><li>OD/Safer injection materials/work useful with constructive engagement/disengagement with peers both in and outside of treatment </li></ul><ul><li>Regulations allow respectful engagement but system can be challenged by practice of this approach </li></ul><ul><li>Resources needed for continuation/expansion </li></ul><ul><li>IMPROVEMENT FOR ALL PROGRAMS!!! </li></ul>
  • 40.  

×